Screening for aberrantly methylated and differentially expressed genes in nonalcoholic fatty liver disease of hepatocellular carcinoma patients with cirrhosis

Table 3 The clinical information of NAFLD/non-NAFLD of HCC patients with cirrhosis

Number	Age	Gender	Drinking history	Smoking history	Family history	HBV infection	HCV infection	AFP (400μg/L)	Classification	Staging
NAFLD	50	Male	Yes	Yes	No	Positive	Negative	1600	2	IIA
NAFLD	60	Male	No	Yes	No	Negative	Negative	1700	2	IIB
NAFLD	59	Male	Yes	Yes	No	Negative	Negative	<400	3	III
NAFLD	54	Male	Yes	No	No	Negative	Negative	680	3	IV
NAFLD	57	Male	No	No	No	Negative	Negative	<400	4	IV
NAFLD	65	Female	No	No	No	Negative	Negative	<400	4	IIB
NAFLD	43	Female	No	No	No	Positive	Negative	635	1	III
Non-NAFLD	47	Male	Yes	Yes	No	Positive	Negative	720	4	IIA
Non-NAFLD	66	Male	No	No	No	Positive	Negative	<400	4	III
Non-NAFLD	60	Male	Yes	Yes	No	Positive	Negative	480	4	IIA
Non-NAFLD	43	Female	No	No	No	Positive	Negative	<400	3	IIB
Non-NAFLD	62	Female	No	No	No	Positive	Negative	1230	2	IV
Non-NAFLD	65	Female	Yes	No	No	Positive	Negative	630	1	IIB

ISSN: 1477-7819